Spanish Red Biotech Pipeline

MSD

Zilovertamab Vedotin (MK2140)

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: A Phase 2 Open-label Clinical Study to Evaluate the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase: 2Phase II in Spain, 1Phase I